M. P. Alvarez-flores, A. Hébert, C. Gouelle, S. Geller, A. M. Chudzinski-tavassi et al., Neuroprotective effect of rLosac on supplement-deprived mouse cultured cortical neurons involves maintenance of monocarboxylate transporter MCT2 protein levels, J. Neurochem, vol.148, pp.80-96, 2019.

D. F. Aschauer, S. Kreuz, and S. Rumpel, Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain, PLoS One, vol.8, p.76310, 2013.

E. Bindocci, I. Savtchouk, N. Liaudet, D. Becker, G. Carriero et al., Three-dimensional Ca2+ imaging advances understanding of astrocyte biology, Science, vol.356, p.8185, 2017.

R. L. Boudreau, I. Martins, and B. L. Davidson, Artificial MicroRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo, Am. Soc. Gene Ther, vol.17, pp.169-175, 2009.

M. Brenner, W. C. Kisseberth, Y. Su, F. Besnard, and A. Messing, GFAP promoter directs astrocyte-specific expression in transgenic mice, J. Neurosci, vol.14, issue.3, pp.1030-1037, 1994.

C. Burger, O. S. Gorbatyuk, M. J. Velardo, C. S. Peden, P. Williams et al., Recombinant AAV Viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system, Mol. Ther, vol.10, pp.302-317, 2004.

R. Calcedo, L. H. Vandenberghe, G. Gao, J. Lin, and J. M. Wilson, Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses, J. Infect. Dis, vol.199, pp.381-390, 2009.

P. Colella, G. Ronzitti, and F. Mingozzi, Emerging issued in AAV-Mediated in Vivo gene therapy, Mol. Ther. Methods Clin. Dev, vol.8, pp.87-104, 2018.

C. B. Colen, N. Seraji-bozorgzad, B. Marples, M. P. Galloway, A. E. Sloan et al., Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: an in vitro study, Neurosurgery, vol.59, pp.1313-1324, 2006.

B. L. Davidson, C. S. Stein, J. A. Heth, I. Martins, R. M. Kotin et al., Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system, Proc. Natl. Acad. Sci. U.S.A, vol.97, pp.3428-3432, 2000.

S. Daya and K. I. Berns, Gene therapy using adeno-associated virus vectors, Clin. Microbiol. Rev, vol.21, pp.583-593, 2008.

B. De-leeuw, M. Su, M. Ter-horst, S. Iwata, M. Rodijk et al., Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements, J. Neurosci. Res, vol.83, pp.744-753, 2006.

C. A. De-solis, M. P. Hosek, R. Holehonnur, A. Ho, A. Banerjee et al., Adeno-associated viral serotypes differentially transduce inhibitory neurons within the rat amygdala, Brain Res, vol.1672, pp.148-162, 2017.

E. R. Detrait, W. J. Bowers, M. W. Halterman, R. E. Giuliano, L. Bennice et al., Reporter gene transfer induces apoptosis in primary cortical neurons, Mol. Ther, vol.5, 2002.

K. S. Dimmer, B. Friedrich, F. Lang, J. W. Deitmer, and S. Bröer, The lowaffinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells, Biochem. J, vol.350, pp.219-227, 2000.

D. J. Dismuke, L. Tenenbaum, and R. J. Samulski, Biosafety of recombinant adeno-associated virus vectors, Curr. Gene Ther, vol.13, pp.1-19, 2013.

B. L. Ellis, M. L. Hirsch, J. C. Barker, J. P. Connelly, I. I. Steininger et al., A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype, Virol. J, vol.10, p.74, 2013.

C. Fellmann, T. Hoffmann, V. Sridhar, B. Hopfgartner, M. Muhar et al., An Optimized microRNA backbone for effective single-copy RNAi, Cell Rep, vol.5, pp.1704-1713, 2013.

T. R. Flotte and K. I. Berns, Adeno-associated virus: a ubiquitous commensal of mammals. Hum, Gene Ther, vol.16, pp.401-407, 2005.

M. Fricker, A. M. Tolkovsky, V. Borutaite, M. Coleman, and G. C. Brown, Neuronal cell death, Physiol. Rev, vol.98, pp.813-880, 2018.

E. Georgiou, K. Sidiropoulou, J. Richter, C. Papaneophytou, I. Sargiannidou et al., Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model, Brain, vol.140, pp.599-616, 2017.

T. Goldmann, P. Wieghofer, P. F. Müller, Y. Wolf, D. Varol et al., A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation, Nat. Neurosci, vol.16, pp.1618-1628, 2013.

Y. Gong, S. Chen, C. F. Sonntag, C. Sumners, R. L. Klein et al., Recombinant adeno-associated virus serotype 2 effectively transduces primary rat brain astrocytes and microglia, Brain Res. Protoc, vol.14, pp.18-24, 2004.

L. R. Gray, R. Sultana, A. J. Rauckhorst, L. Oonthonpan, S. C. Tompkins et al., Hepatic mitochondrial pyruvate carrier 1 Is required for efficient regulation of gluconeogenesis and whole-body glucose homeostasis, Cell Metabol, vol.22, pp.669-681, 2015.

S. J. Gray, S. B. Foti, J. W. Schwartz, L. Bachaboina, B. Taylor-blake et al., Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors, Hum. Gene Ther, vol.22, pp.1143-1153, 2011.

D. Grimm, J. S. Lee, L. Wang, T. Desai, B. Akache et al., In Vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses, J. Virol, vol.82, pp.5887-5911, 2008.

A. P. Halestrap, The SLC16 gene family -structure, role and regulation in health and disease, Mol. Aspects Med, vol.34, pp.337-349, 2013.

A. P. Halestrap and N. T. Price, The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation, Biochem. J, vol.343, pp.281-299, 1999.

C. Hinderer, N. Katz, E. L. Buza, C. Dyer, T. Goode et al., Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expression human SMN. Hum, Gene Ther, vol.29, pp.285-298, 2018.

M. D. Hoggan, N. R. Blacklow, and W. P. Rowe, Studies of small DNA viruses found in various adenovirus preparations: physical, biological and immunological characteristics, Proc. Natl. Acad. Sci. U.S.A, vol.55, pp.1467-1474, 1966.

R. Holehonnur, J. A. Luong, D. Chaturvedi, A. Ho, S. K. Lella et al., Adeno-associated viral serotypes produce differing titers and differentially transduce neurons within the rat basal and lateral amygdala, BMC Neurosci, vol.15, p.28, 2014.

D. B. Howard, K. Powers, Y. Wang, and B. K. Harvey, Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, 9 in rat neurons and glia in vitro, Virology, vol.372, pp.24-34, 2008.

J. Iglesias, L. Morales, and G. E. Barreto, Metabolic and inflammatory adaptation of reactive astrocytes: role of PPARs, Mol. Neurobiol, vol.54, pp.2518-2538, 2017.

M. Jang, S. E. Lee, and I. H. Cho, Adeno-associated viral vector serotype DJ-mediated overexpression of N171-82Q-mutant huntingtin in the striatum of juvenile mice is a new model for huntington's disease. Front, Cell. Neurosci, vol.12, p.157, 2018.

F. Jiang and J. A. Doudna, CRISPR -Cas9 structures and mechanisms, Annu. Rev. Biophys, vol.46, pp.505-529, 2017.

Y. Lee, A. Messing, M. Su, and M. Brenner, GFAP promoter elements required for region-specific and astrocyte-specific expression, Glia, vol.56, pp.481-493, 2008.

G. Liu, I. H. Martins, J. A. Chiorini, and B. L. Davidson, Adeno-associated virus type 4 (AAV4) targets ependymal and astrocytes in the subventricular zone and RMS, Gene Ther, vol.12, pp.1503-1508, 2005.

H. S. Liu, M. S. Jan, C. K. Chou, P. H. Chen, and N. J. Ke, Is green fluorescent protein toxic to the living cells?, Biochem. Biophys. Res. Commun, vol.260, pp.712-717, 1999.

J. Macarthur-clarke, The 3Rs in research: a contemporary approach to replacement, reduction and refinement, Br. J. Nutr, vol.12, pp.1-7, 2018.

F. Maekawa, K. Minehira, K. Kadomatsu, and L. Pellerin, Basal and stimulated lactate fluxes in primary cultures of astrocytes are differentially controlled by distinct proteins, J. Neurochem, vol.107, pp.789-798, 2008.

F. Marcillac, B. Brix, C. Repond, O. Jöhren, and L. Pellerin, Nitric oxide induces the expression of the monocarboxylate transporter MCT4 in cultured astrocytes by a cGMP-independent transcriptional activation, Glia, vol.59, 1987.

L. Mazuel, J. Blanc, C. Repond, V. Bouchaud, G. Raffard et al., A neuronal MCT2 knockdown in the rat somatosensory cortex reduces both the NMR lactate signal and the BOLD response during whisker stimulation, PLoS One, vol.12, p.174990, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02348315

N. Merienne, G. Vachey, L. De-longprez, C. Meunier, V. Zimmer et al., The selt-inactivating KamiCas9 system for the editing of CNS disease genes, Cell Rep, vol.20, pp.2980-2991, 2017.

C. Meunier, N. Merienne, C. Jollé, N. Déglon, and L. Pellerin, Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of huntington's disease, Glia, vol.64, pp.1841-1856, 2016.

G. Paxinos and C. Watson, Compact, 3rd Edn, The Rat Brain in Stereotaxic Coordinates, 1996.

L. Pellerin and P. J. Magistretti, Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization, Proc. Natl. Acad. Sci. U.S.A, vol.91, pp.10625-10629, 1994.

L. Pellerin and P. J. Magistretti, Sweet sixteen for ANLS, J. Cereb. Blood Flow Metab, vol.32, pp.1152-1166, 2012.

K. Pierre and L. Pellerin, Monocarboxylate transporters in the central nervous system: distribution, regulation and function, J. Neurochem, vol.94, pp.1-14, 2005.

C. Préhaud, F. Mégret, M. Lafage, and M. Lafon, Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon, J. Virol, vol.79, pp.12893-12904, 2005.

D. D. Rao, J. S. Vorhies, N. Senzer, and J. Nemunaitis, siRNA vs. shRNA: similarities and differences, Adv. Drug Deliv. Rev, vol.61, pp.746-759, 2009.

K. Rosafio, X. Castillo, L. Hirt, and L. Pellerin, Cell-specific modulation of monocarboxylate transporter expression contributes to the metabolic reprograming taking place following cerebral ischemia, Neuroscience, vol.317, pp.108-120, 2016.

K. Rosafio and L. Pellerin, Oxygen tension controls the expression of the monocarboxylate transporter mct4 in cultured mouse cortical astrocytes via a hypoxia-inducible factor-1?-mediated transcriptional regulation, Glia, vol.64, pp.477-490, 2014.

A. M. Rosario, P. E. Cruz, C. Ceballos-diaz, M. R. Strickland, Z. Siemienski et al., Microglia-specific targeting by novel capsid-modified AAV6 vectors, Mol. Ther. Methods Clin. Dev, vol.3, p.16026, 2016.

A. L. Schober, D. A. Gagarkin, Y. Chen, G. Gao, L. Jacobson et al., Recombinant adeno-associated virus serotype 6 (AAV6) potently and preferentially transduced rat astrocytes in vitro and in vivo, Front. Cell. Neurosci, vol.10, p.262, 2016.

Z. Shevtsova, J. M. Malik, U. Michel, M. Bähr, and S. Kügler, Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo, Exp. Physiol, vol.90, pp.53-59, 2004.

M. V. Sofroniew, Astrogliosis. Cold Spring Harb. Perspect. Biol, vol.7, issue.020420, 2015.

A. Suzuki, S. A. Stern, O. Bozdagi, G. W. Huntley, R. H. Walker et al., Astrocyte-neuron lactate transport is required for long-term memory formation, Cell, vol.144, pp.810-823, 2011.

G. Von-jonquieres, N. Mersmann, C. B. Klugmann, A. E. Harasta, B. Lutz et al., Glial promoter selectivity following AAV-Delivery to the immature brain, PLoS One, vol.8, p.65646, 2013.

Z. Wang, H. I. Ma, J. Li, L. Sun, J. Zhang et al., Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo, Gene Ther, vol.10, pp.2105-2111, 2003.

Z. Wu, E. Miller, M. Agbandje-mckenna, and R. J. Samulski, ?2,3 and ?2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6, J. Virol, vol.80, pp.9093-9103, 2006.